Renal Ewing sarcoma treated with apatinib.
Anticancer Drugs
; 29(7): 702-704, 2018 08.
Article
en En
| MEDLINE
| ID: mdl-29782348
ABSTRACT
Renal Ewing sarcoma (RES) is an extremely rare disease. The standard treatment for this disease is lacking, and clinical experience needs to be accumulated. Here, we report a case of RES that rapidly developed to metastatic disease and was refractory to radiotherapy and chemotherapy; however, the case obtained a partial response based on Choi criteria by orally taking antiangiogenic drug apatinib. Our case suggests that apatinib may be a therapeutic option for RES.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Piridinas
/
Sarcoma de Ewing
/
Neoplasias Renales
/
Antineoplásicos
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Anticancer Drugs
Asunto de la revista:
ANTINEOPLASICOS
Año:
2018
Tipo del documento:
Article